Ironwood Pharma (IRWD) Reports Q1 Lost Per Share of 24c

Ironwood Pharma (NASDAQ: IRWD) reported Q1 EPS of ($0.24), may note compare the analyst estimate of ($0.23). Revenue for the quarter came in at $28.9 million versus the consensus estimate of $32.3 million.

For earnings history and earnings-related data on Ironwood Pharma (IRWD) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• Indosat Tbk PT (ISAT:IJ) (PTITF) PT Raised to IDR35.10 at JPMorgan
• BofA Securities Starts PhysicsWallah Ltd (PWL:IN) at Underperform